Oncotarget is a peer-reviewed open access journal that deals with the care of cancer patients. It looks at the pathology of cancer, treatment procedures and therapy targets to give the best possible care to affected patients. The journal also does in-depth reviews on the latest and existing therapies as well as the quality of life and satisfaction from the patients’ point of view. It also generally covers all aspects of oncology. Oncotarget was launched in 2010 and is published by Impact Journals with Mikhail Blagosklonny and Andrei Gudkov as its editors-in-chief. Visit his profile on Google Scholar.
With the increasing use of e-cigarettes, a paper published on Oncotarget from URMC Rochester concerning the damage it causes on the gum tissue is one of the articles that shows how vital Oncotarget can be. The increase in e-cigarette usage posed an oral health concern leading to the research being done to address this issue. Oncotarget being a stakeholder in oral health matters, published this upon reception from URMC and became available for public consumption for the first time. As such, the platform played a major role in providing this crucial information out to the general public on a global scale.
In this paper, findings showed that e-cigarette vapor caused inflammatory responses and DNA damage in human periodontal ligament fibroblasts, gingival epithelium progenitors, pooled cells, and epi-gingival tissues. This confirmed that e-cigarettes do indeed cause gum tissue damage. The detailed nature of this report is one of the examples that clearly demonstrate how resourceful Oncotarget can be.
The information available on the site can be used by a wide range of individuals from oncologists to students who might find the information useful in their work and study, as well as inform the general public. The information is easily accessible, and Oncotarget offers its users an option to download the published paper for portability and frequent access. It is arguably one of the best electronic resources of information as long as the medical and education sectors are concerned. It is also vital in increasing the impact of its authors’ research by reaching a worldwide audience. Oncotarget currently accepts papers of a wide range of areas other than oncology be it cardiology, neurology, pharmacology among many others and get it out there as far as it is possible. Download output styles at Endnote.com